ChemoMetec AS (CHIX:CHEMMC) ROE % Adjusted to Book Value : 3.12% (As of Dec. 2024)

View and export this data going back to 2013. Start your Free Trial

What is ChemoMetec AS ROE % Adjusted to Book Value?

ChemoMetec AS's ROE % for the quarter that ended in Dec. 2024 was 35.54%. ChemoMetec AS's PB Ratio for the quarter that ended in Dec. 2024 was 11.40. ChemoMetec AS's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was 3.12%.

ChemoMetec AS ROE % Adjusted to Book Value Historical Data

The historical data trend for ChemoMetec AS's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ChemoMetec AS ROE % Adjusted to Book Value Chart

ChemoMetec AS Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

1.16

0.67

1.39

2.63

2.12

ChemoMetec AS Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															1.92	1.94	2.17	2.11	3.12

Competitive Comparison of ChemoMetec AS's ROE % Adjusted to Book Value

For the Medical Devices subindustry, ChemoMetec AS's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ChemoMetec AS's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ChemoMetec AS's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where ChemoMetec AS's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

ChemoMetec AS ROE % Adjusted to Book Value Calculation

ChemoMetec AS's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	24.82%	/	11.69
	=	2.12%

ChemoMetec AS's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	35.54%	/	11.40
	=	3.12%

ChemoMetec AS ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of ChemoMetec AS's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

ChemoMetec AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ChemoMetec AS (CHIX:CHEMMc) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

0DZ0:UK CHEMM:Denmark CHY:Germany

Address

Gydevang 43, Allerod, DNK, 3450

Website

https://www.chemometec.com

ChemoMetec AS specializes in designing, developing, and producing instruments using patented technology in cell counting and evaluation. It is engaged in the manufacturing and marketing of analytical instruments used for quantitative analysis of cells in liquids. Its applications include Cell Analysis and counting of Mammalian Cells, Yeast Cells, and Sperm Cells. It provides platforms for the determination of viability and cell count of yeast, veterinary semen, mammalian cells, and somatic cells as well as image analysis. It has four segments instruments; consumables; services and others, and the majority of its revenue is generated from the Consumable segment.

ChemoMetec AS Headlines

No Headlines